Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 32 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
311 21.2 months Metastatic, castration-resistant prostate cancer 5 Chemotherapy
Hormone
Princess Margaret Cancer Center Canada 7/2013
Treatment Details: Patients: This phase 3 study involved metastatic castration-resistant prostate cancer patients who had not received prior chemotherapy and who were divided into two separate treatment group
 
312 21.2 months Recurrent ovarian cancer or peritoneal cancer 4 Chemotherapy
Wayne State University School of Medicine United States 6/2008
Treatment Details: Patients: This phase II study involved 41 women with ovarian or peritoneal cancer. The majority (88%) had stage III/IV ovarian cancer. The median age was 62, ranging from 42 to 82 years o
 
313 21.2 months Newly diagnosed GBM 5 Biologic therapy
Chemotherapy
Radiation
Duke University Medical Center United States 6/2011
Treatment Details: Patients: This phase II study involved 75 patients with newly diagnosed glioblastoma. Of the patients, 45 were male and the median age was 55.6 years. Treatment: Patients were treated
 
314 21.1 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Klinikum Muenchen-Grosshadern Germany 3/2011
Treatment Details: Patients: This phase 2 study involved metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A consisted of 89 patients with a median age of 63 ye
 
315 21.1 months Metastatic rcc 3 Immunotherapy
University of Texas M. D. Anderson Cancer Center United States 7/2008
Treatment Details: Patients: This phase II study involved 44 patients with metastatic renal cell carcinoma (kidney cancer). The median age was 64 years, and the majority (64%) of patients were men. Treatm
 
316 21.1 months GBM Immunotherapy
Cedars-Sinai Medical Center United States 7/2008
Treatment Details: Patients: This phase 2 study involved 34 patients with glioblastoma multiforme. There were 10 women and 24 men, ranging in age from 22 to 74 years. Treatment: Patients were treated wit
 
317 21.1 months recurrent ovarian cancer 4 Chemotherapy
Cedars Sinai Medical Center United States 3/2005
Treatment Details: Patients: This Phase II study involved 25 women with recurrent ovarian cancer. The median age was 61, and all patients had received at least one treatment before this study. Treatment: T
 
318 21.1 months Metastatic Breast Cancer 4 Biologic therapy
Chemotherapy
University General Hospital of Heraklion Greece 11/2014
Treatment Details: Patients: This study involved 48 HER2-negative metastatic breast cancer patients who had received prior chemotherapy. The median patient age was 61.0 years. Treatment: Patients receive
 
319 21.0 months Metastatic breast cancer 5 Biologic therapy
Chemotherapy
St. Louis Cancer and Breast Institute United States 10/2012
Treatment Details: Patients: This phase 2 study involved 52 female metastatic breast cancer patients. The median patient age was 55 years. Treatment: Patients were treated with the chemotherapy agent gem
 
320 21.0 months Stage IV melanoma 4 Biologic therapy
Immunotherapy
University of Pittsburgh Cancer Institute United States 12/2011
Treatment Details: Patients: This study involved 37 patients with stage IV melanoma. The median patient age was 56 years and 62% were male. Treatment: Patients were treated with the biologic therapy ag
 
Page 32 of 187  | Previous Page  | Next Page